|
Marché Fermé -
Nasdaq
22:00:00 13/11/2026
|
Varia. 5j. | Varia. 1 janv. | ||
| 10,03 USD | -5,82% |
|
-54,51% | -6,00% |
| 09/11 | Valeurs en forte baisse à la mi-séance | MT |
| 09/11 | Faeth Therapeutics annonce un taux de réponse de 33 % dans un essai de phase 2 sur le cancer de l’endomètre ; l’action recule | MT |
Principaux concurrents
Ajouter à une liste 0 sélectionné | Varia. | Varia. 5j. | Variation 1 mois | Variation 3 mois | Varia. 1 janv. | Varia. 1an | Varia. 3ans | Varia. 5ans | Varia. 10ans | Capi.($) | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -5,82% | -54,51% | -49,85% | -68,99% | -6,00% | +25,30% | -33,13% | -94,79% | - | 259 M | |
| -2,69% | -0,48% | -5,11% | -8,13% | +61,41% | +53,97% | +70,99% | +13,50% | - | 66,33 Md | |
| -0,92% | +7,67% | +17,72% | +20,30% | +22,54% | +12,64% | +92,55% | +224,85% | +6 178,77% | 60,62 Md | |
| 0,00% | +0,39% | +13,77% | +18,38% | +23,84% | +22,34% | +90,83% | -9,63% | +276,70% | 55,5 Md | |
| +0,14% | +2,35% | +18,51% | +19,87% | +37,11% | +13,86% | +106,64% | +10,00% | +1 088,42% | 47,58 Md | |
| -2,21% | -2,47% | +1,19% | +12,03% | +17,62% | +20,18% | +32,24% | +4,10% | +244,80% | 43,69 Md | |
| -2,30% | -10,40% | -10,97% | -15,42% | +116,31% | +154,30% | +725,54% | +424,79% | - | 37,27 Md | |
| +2,15% | +1,42% | +19,02% | +6,47% | +24,14% | +14,58% | +54,23% | +21,92% | +193,10% | 36,57 Md | |
| -2,32% | -2,24% | +38,98% | +70,10% | +70,10% | +76,50% | +54,55% | +22,18% | +186,86% | 32,22 Md | |
| +2,62% | +5,90% | +23,90% | -2,09% | -30,38% | -37,29% | +393,72% | +280,29% | +701,85% | 26,58 Md | |
| -4,38% | -1,85% | -6,03% | +3,54% | +48,66% | +40,28% | -2,22% | -55,49% | - | 24,45 Md | |
| +0,66% | -2,18% | -3,45% | -8,05% | -10,08% | -16,97% | -14,96% | -64,05% | - | 21,22 Md | |
| -0,44% | +0,13% | +6,05% | +13,04% | +16,43% | +10,82% | +131,76% | +194,74% | +1 785,10% | 18,29 Md | |
| +3,12% | +7,23% | +21,32% | +10,82% | - | - | - | - | - | 18,06 Md | |
| +1,10% | +8,66% | +15,97% | -8,00% | +225,70% | +218,59% | +393,11% | +1 472,94% | +873,51% | 17,38 Md | |
| -1,20% | -0,82% | +13,13% | +34,66% | +57,43% | +65,67% | +222,88% | +281,22% | +311,69% | 16,84 Md | |
| +0,02% | -0,74% | +13,00% | +24,90% | +40,99% | +49,22% | +69,00% | -16,98% | +119,95% | 16,58 Md | |
| -0,83% | +0,13% | +11,91% | +20,68% | +69,43% | +101,40% | +89,48% | -12,42% | +350,27% | 16,19 Md | |
| -2,92% | -4,93% | +15,20% | +19,31% | +6,82% | +20,02% | -27,08% | -31,83% | +140,81% | 14,58 Md | |
| -2,18% | -1,50% | +2,47% | -13,93% | +14,23% | -3,66% | +417,92% | - | - | 13,65 Md | |
| Moyenne | -0,92% | -2,89% | +7,84% | +7,48% | +42,44% | +44,30% | +150,95% | +148,07% | +957,83% | 29 Md | |
| Moyenne pondérée par Capi. | -0,80% | +0,01% | +10,33% | +11,41% | +42,82% | +41,21% | +147,76% | +126,14% | +1 358,41% |
- Bourse
- Actions
- Action FTH
- Secteur Faeth Therapeutics, Inc.
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
